Cargando…
RAGE Inhibitors for Targeted Therapy of Cancer: A Comprehensive Review
The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin family that is overexpressed in several cancers. RAGE is highly expressed in the lung, and its expression increases proportionally at the site of inflammation. This receptor can bind a variety of ligands, inclu...
Autores principales: | Faruqui, Tabrez, Khan, Mohd Sajid, Akhter, Yusuf, Khan, Salman, Rafi, Zeeshan, Saeed, Mohd, Han, Ihn, Choi, Eun-Ha, Yadav, Dharmendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820344/ https://www.ncbi.nlm.nih.gov/pubmed/36613714 http://dx.doi.org/10.3390/ijms24010266 |
Ejemplares similares
-
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
por: Singh, Desh Deepak, et al.
Publicado: (2023) -
Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Plasma
por: Han, Ihn, et al.
Publicado: (2022) -
Carvacrol instigates intrinsic and extrinsic apoptosis with abrogation of cell cycle progression in cervical cancer cells: Inhibition of Hedgehog/GLI signaling cascade
por: Ahmad, Afza, et al.
Publicado: (2023) -
CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer
por: Deepak Singh, Desh, et al.
Publicado: (2021) -
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
por: Singh, Desh Deepak, et al.
Publicado: (2020)